A study in The Journal of Urology highlighted the potential of the MyProstateScore 2.0 (MPS2) urine test to reduce unnecessary prostate biopsies by up to 42%. A study in JAMA Neurology found that certain headache disorders, such as migraine and tension-type headaches, are associated with a higher risk of suicide attempts and deaths compared to the general population. A phase 3 trial in The New England Journal of Medicine found that obinutuzumab, combined with standard therapy, significantly improved renal outcomes in patients with active lupus nephritis.
